CLINICAL SUPPLY LOGISTIC ARTICLES
Post-Acquisition Clinical Supply Chain Risk: Continuity Before Consolidation
Acquisitions can disrupt clinical trial supply when knowledge, decision rights, inventory data, and supplier responsibilities fail to transfer. Learn how to protect continuity.
CLINICAL SUPPLY LOGISTIC VIDEOS
Coordinating drug substance, analytics, and clinical ops across multiple vendors puts you in the integrator role. See how connected CDMO-CRO partnerships eliminate that burden and reduce downstream risk.
Automated storage and retrieval technology reduces mis-picks, speeds order processing, and keeps clinical trial materials moving on time as study demands shift.
Investigational products present a distinctly high-risk environment for labeling and barcoding. Explore best practices for barcoding solutions that allow for improved medication safety in clinical trials.
See how innovative packaging engineering approaches are helping study teams adapt to evolving clinical trial requirements with greater speed and flexibility.
CLINICAL SUPPLY LOGISTIC RESOURCES
-
![doctor holding vial of medicine-GettyImages-1287223643]( "Internal Validation Study: Ultra-Low Temperature Labels")
Clinical trial vials held at ultra-low temperatures need labels that stay put. Three label formats, applied under dry ice conditions, were compared for qualification.
-
![Healthcare, medicine, medical supplies-GettyImages-1773074070]( "Ancillary Supplies Can Delay A Trial Just As Quickly As An IMP Issue")
Everything in a trial except the drug can stall it just as fast. Country-specific device rules, late regulatory review, and closeout paperwork shape whether global supply holds up.
-
![GettyImages-139602926 labeling, packaging, pharma]( "Ultra-Low Temperature Clinical Labels: An Interview With Julia Field")
Labels for vaccines and advanced therapies stored at –80°C or –196°C must hold adhesion and legibility without thawing the product. Material qualification, not standard stock, determines whether they perform.
-
![Accelerate Drug Development With Phase-Appropriate Thinking_Siegfried]( "QP Certification Of Investigational Medicinal Products In The EU And UK")
Personal legal responsibility, post-Brexit certification rules, and a three-part documentation review shape how investigational batches reach patients in the EU and UK, and how sponsors work with their certifying QP.
-
![3_PharmaSource_Conference_CDMO Live copy]( "Vertex On Building Risk Into Manufacturing Network Strategy")
Supply disruptions are becoming harder to predict. Explore practical strategies for continuity planning, supplier risk management, and network design to build lasting resilience.
-
![Export-Import Logistics system-GettyImages-1333159181]( "Clinical Trial Logistics: What Biopharma Needs To Prepare For Next")
Fragmented clinical trial logistics are slowing programs and increasing risk. Learn how coordinated planning and digital visibility are becoming competitive advantages in complex, global studies.
-
![Import export, logistics-GettyImages-543194530]( "Clinical Supply Flexibility Where Biotech Programs Need It Most")
Flexible clinical development requires scalable infrastructure, strong project management, and global logistics to ensure supply continuity and regulatory compliance.
